SEER cancer statistics review, 1975–2010 N Howlader, AM Noone, M Krapcho, J Garshell, N Neyman, SF Altekruse, ... Bethesda, MD: National Cancer Institute 21, 12, 2013 | 11519* | 2013 |
SEER cancer statistics review 1975-2005 AGEA RATES, AGES RATES | 1453 | 2008 |
SEER cancer statistics review, 1975-2007 SF Altekruse http://seer. cancer. gov/csr/1975_2007/results_merged/sect_13_leukemia. pdf, 2009 | 1367 | 2009 |
The decrease in breast-cancer incidence in 2003 in the United States PM Ravdin, KA Cronin, N Howlader, CD Berg, RT Chlebowski, EJ Feuer, ... New England Journal of Medicine 356 (16), 1670-1674, 2007 | 1188 | 2007 |
Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program MJ Hayat, N Howlader, ME Reichman, BK Edwards The oncologist 12 (1), 20-37, 2007 | 1134 | 2007 |
SEER cancer statistics review, 1975–2013 N Howlader, AM Noone, M Krapcho, D Miller, K Bishop, SF Altekruse, ... Bethesda, MD: National Cancer Institute 19, 2016 | 1098 | 2016 |
SEER cancer statistics review, 1975–2012 N Howlader, AM Noone, M Krapcho, J Garshell, D Miller, SF Altekruse, ... Bethesda, MD: National Cancer Institute 2015, 2015 | 1087 | 2015 |
SEER cancer statistics review, 1975-2015 AM Noone, N Howlader, M Krapcho, D Miller, A Brest, M Yu, J Ruhl, ... Bethesda, MD: National Cancer Institute 4, 2018 | 1030 | 2018 |
SEER cancer statistics review, 1975–2011 N Howlader, AM Noone, M Krapcho, J Garshell, D Miller, SF Altekruse, ... Bethesda, MD: National Cancer Institute 19, 2014 | 1028 | 2014 |
Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state BA Kohler, RL Sherman, N Howlader, A Jemal, AB Ryerson, KA Henry, ... JNCI: Journal of the National Cancer Institute 107 (6), 2015 | 707 | 2015 |
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs DE Rollison, N Howlader, MT Smith, SS Strom, WD Merritt, LA Ries, ... Blood, The Journal of the American Society of Hematology 112 (1), 45-52, 2008 | 686 | 2008 |
SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD N Howlader, AM Noone, M Krapcho, J Garshell, N Neyman, SF Altekruse, ... | 668 | 2013 |
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status N Howlader, SF Altekruse, CI Li, VW Chen, CA Clarke, LAG Ries, ... JNCI: Journal of the National Cancer Institute 106 (5), 2014 | 661 | 2014 |
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics KA Cronin, AJ Lake, S Scott, RL Sherman, AM Noone, N Howlader, ... Cancer 124 (13), 2785-2800, 2018 | 608 | 2018 |
SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD SF Altekruse, CL Kosary, M Krapcho, N Neyman, R Aminou, W Waldron, ... | 590 | 2010 |
SEER cancer statistics review, 1975-2016 N Howlader, AM Noone, M Krapcho, D Miller, A Brest, M Yu, J Ruhl, ... National Cancer Institute, 2019 | 566 | 2019 |
SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD N Howlader, AM Noone, M Krapcho, J Garshell, D Miller, SF Altekruse, ... | 529 | 2015 |
SEER cancer statistics review, 1975-2005, National cancer institute. Bethesda, MD LAG Ries, D Melbert, M Krapcho, DG Stinchcomb, N Howlader, ... | 446* | 2008 |
Improved estimates of cancer-specific survival rates from population-based data N Howlader, LAG Ries, AB Mariotto, ME Reichman, J Ruhl, KA Cronin JNCI: Journal of the National Cancer Institute 102 (20), 1584-1598, 2010 | 368 | 2010 |
SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD N Howlader, AM Noone, M Krapcho, J Garshell, D Miller, SF Altekruse, ... | 358 | 2014 |